Presentation Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS Presenter: Andr?s Kom?csi October 01, 2012 REGISTER for free or LOG IN to view this content ACS/AMI Prevention CAD Pharma Clinical Pharma Factoid Up Next Presentation Incidence and Clinical Impact of Stent Fracture After Everolimus-Eluting Stent (EES) Implantation Presenter: Shoichi Kuramitsu October 01, 2012 More slides + Presentation Gender-Related Trends in Mortality in Hospitalized Men and Women After MI Between 1985 and 2008 Presenter: Sjoerd T. Nauta October 02, 2012 Presentation Efficacy and Safety of Apixaban vs. Warfarin Based on Patient Risk of Stroke and Bleeding in A-fib Presenter: Renato D. Lopes October 03, 2012 We Recommend
Presentation Incidence and Clinical Impact of Stent Fracture After Everolimus-Eluting Stent (EES) Implantation Presenter: Shoichi Kuramitsu October 01, 2012
Presentation Gender-Related Trends in Mortality in Hospitalized Men and Women After MI Between 1985 and 2008 Presenter: Sjoerd T. Nauta October 02, 2012
Presentation Efficacy and Safety of Apixaban vs. Warfarin Based on Patient Risk of Stroke and Bleeding in A-fib Presenter: Renato D. Lopes October 03, 2012